Legislation
The American Pharmacists Association Writes Congress to Oppose Importation
On March 22, the American Pharmacists Association (APhA), which represents 64,000 pharmacists, pharmacy technicians, pharmacy students and other pharmacy professionals wrote a letter to Congress opposing plans to legalize importation of non-FDA approved drugs. These proposals, they wrote, are “in direct conflict with recent efforts by Congress and federal agencies to increase the integrity and security of the U.S. drug supply.”
[...]Former FDA Commissioners Warn About Drug Importation
The Washington Post reports that the four most recent FDA commissioners have warned Congress that American patients will suffer if they import drugs from other countries, citing fake, substandard and contaminated drugs as potential consequences.
[...]Pew Trust Warns Senator Sanders that Drug Import Bill Could Compromise the Safety of the U.S. Drug Supply
On Tuesday, February 28, Allan Coukell, Senior Director of Health Programs for the Pew Charitable Trusts, wrote Senator Bernie Sanders to ask that he not undermine safety protections for medication with the Affordable and Safe Prescription Drug Importation Act.
[...]The Partnership for Safe Medicines Letter to Congress – February 28, 2017
The Partnership for Safe Medicines (PSM) today sent a letter to all members of Congress urging them to continue protecting Americans and stand against efforts that would allow substandard and even dangerous counterfeit medicines to flow freely across U.S. borders and into the hands of the American people. The letter, signed by nearly 170 groups, is…
[...]Over 30 Groups Nationally Oppose Drug Importation
Recently, conversations and debate about drug importation has reached a fever pitch. Partnership For Safe Medicines’ many coalition members want Congress to know about our concerns for the safety of American patients. The secure American drug supply chain protects American consumers from dangerous counterfeit, substandard and unsafe medicines. Any effort designed to bypass FDA controls…
[...]In 2013, Maine became the 1st state in the country to enact a “drug importation ordinance.”
By February of 2015 the law had been thrown out, but only after the President of the Maine Pharmacy Association experienced first hand what patients can be exposed to when buying drugs from a Canadian online pharmacy. On June 27, 2013, the Maine Legislature passed LD 171, the Act to Facilitate Personal Importation of Prescription…
[...]Did You Ever Wonder Why People Buy Counterfeit Drugs?
Last month, the Wall Street Journal featured an article that discussed the efforts currently underway to deter people from buying counterfeit products. It pointed out that many anti-counterfeiting messages fail to address the underlying motivation which leads people to buy counterfeit products.
[...]No Such Thing as a “Safe Country” for Drug Importation
With talks about drug importation continuing in Congress, drug importation supporters argue that if the United States allows importation only from “safe countries,” such as Canada and the United Kingdom, than most of drug safety concerns would be eliminated. However, when it comes to drug importation, there is no such thing as a “safe” country.
[...]Tougher Penalties for Counterfeiters Under Consideration
On June 4, Rep. Steve J. Israel (D-NY) introduced the Counterfeit Enforcement Act of 2009 (H.R. 2726). This proposed legislation, which would amend the Federal Food, Drug and Cosmetic Act, increases penalties for the sale of contraband or counterfeit drugs. If passed, this legislation brings to life many of the ideas that the Partnership for Safe Medicines advocates in the Principles for Drug Safety.
[...]Congress on the Right Road to Stop Drug Counterfeiters
Earlier this year, Reps. John D. Dingell (D-MI 15), Frank Pallone, Jr. (D-NJ 06) and Bart Stupak (D-MI 01) introduced the Food and Drug Administration Globalization Act of 2009 (H.R.759). This legislation indicates that Congress is fbeginning an important journey to address several real threats that substandard and counterfeit drugs pose to the pharmaceutical supply chain.
[...]